ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,092Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 107

$933K Total Retail Price of All Prescriptions

Rank: 11 out of 107

249 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 249 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

5% of this provider’s 249 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 13,837 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

57 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 786 774 1 3
JANTOVEN 556 556 2 62
LEVOTHYROXINE SODIUM 502 502 3 1
OMEPRAZOLE 435 422 4 6
SIMVASTATIN 400 400 5 2
MIRTAZAPINE 392 391 6 16
DONEPEZIL HCL 360 359 7 10
METOPROLOL TARTRATE 353 340 8 7
AMLODIPINE BESYLATE 320 320 9 5
LISINOPRIL 306 302 10 4
TRAZODONE HCL 287 287 11 22
ESCITALOPRAM OXALATE 283 272 12 40
POLYETHYLENE GLYCOL 3350 277 277 13 24
CYMBALTA 256 256 14 52
NAMENDA 255 254 15 19
SERTRALINE HCL 235 235 16 12
CITALOPRAM HBR 204 204 17 9
POTASSIUM CHLORIDE 173 173 18 18
PREDNISONE 156 138 19 39
KETOCONAZOLE 144 141 20 160
FAMOTIDINE 142 142 21 42
ALBUTEROL SULFATE 135 135 22 67
ABILIFY 126 126 23 66
IPRATROPIUM-ALBUTEROL 120 120 24 49
ISOSORBIDE MONONITRATE ER 119 119 25 30
ATENOLOL 110 110 26 21
CLOPIDOGREL 107 107 27 29
GABAPENTIN 106 106 28 11
OXYCODONE-ACETAMINOPHEN 105 93 S2 29 53
METOPROLOL SUCCINATE 105 105 29 15
DIVALPROEX SODIUM 102 95 31 55
LEVOFLOXACIN 93 93 32 101
CARVEDILOL 90 90 33 25
GLIPIZIDE 89 89 34 46
RANITIDINE HCL 86 86 35 41
LIDODERM 85 85 36 77
HYDROCORTISONE 84 78 37 181
DIGOXIN 83 83 38 37
IPRATROPIUM BROMIDE 81 81 39 147
FENTANYL 81 56 S2 39 50
PLAVIX 80 80 41 43
AMOXICILLIN 77 77 42 201
FLUOCINOLONE ACETONIDE 76 74 43 335
OLANZAPINE 75 75 44 57
ZETIA 74 74 45 126
LANTUS 72 72 46 34
FINASTERIDE 72 72 46 72
PROCTOZONE-HC 72 72 46 223
LOSARTAN POTASSIUM 71 71 49 36
ENALAPRIL MALEATE 68 68 50 70
FLUTICASONE PROPIONATE 64 48 51 54
VENLAFAXINE HCL ER 63 63 52 75
TRAMADOL HCL 63 63 52 23
ATORVASTATIN CALCIUM 62 55 54 17
LAMOTRIGINE 60 60 55 86
ERYTHROMYCIN 59 59 56 253
TRAVATAN Z 59 59 56 210
LEXAPRO 57 55 58 163
METOLAZONE 57 57 58 168
CARBIDOPA-LEVODOPA 55 55 60 56
VOLTAREN 54 52 61 172
RISPERIDONE 54 54 61 26
OXYBUTYNIN CHLORIDE 52 52 63 118
ADVAIR DISKUS 52 52 63 47
LATANOPROST 51 51 65 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.